TIDMGSK

RNS Number : 4344F

GlaxoSmithKline PLC

12 July 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  ============================================ 
 b)   Position/status          Chief Executive Officer 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    19 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr R G Connor 
===  ========================  ============================================ 
 b)   Position/status          President, Global Vaccines 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    62 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  ============================================ 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    12 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mrs S Jackson 
===  ========================  ============================================ 
 b)   Position/status          SVP, Global Communications and CEO Office 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    57 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Mr D Jackson 
===  ========================  ================================================ 
 b)   Position/status          PCA of Mrs S Jackson (SVP, Global Communications 
                                and CEO Office) 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    19 
                                               ---------- 
===  ========================  ================================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ================================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr L Miels 
===  ========================  ============================================ 
 b)   Position/status          President, Global Pharmaceuticals 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    3 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr D S Redfern 
===  ========================  ============================================ 
 b)   Position/status          Chief Strategy Officer 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    70 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  ============================================ 
 b)   Position/status          President, Pharmaceuticals Supply Chain 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    19 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr P C Thomson 
===  ========================  ============================================ 
 b)   Position/status          President, Global Affairs 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    40 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mrs V A Whyte 
===  ========================  ============================================ 
 b)   Position/status          Company Secretary 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019, on shares 
                                held through the Company's Share Reward 
                                Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP16.5060    51 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-07-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHZLLFFKDFEBBF

(END) Dow Jones Newswires

July 12, 2019 10:55 ET (14:55 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.